Sebastian M Schellong Selected Research

Sebastian M Schellong Research Topics

10	Venous Thromboembolism 01/2018 - 07/2010
10	Hemorrhage 03/2017 - 07/2010
7	Venous Thrombosis (Deep-Vein Thrombosis) 07/2022 - 02/2003
4	Thrombosis (Thrombus) 02/2018 - 11/2003
4	Pulmonary Embolism 01/2018 - 02/2011
3	Stroke (Strokes) 10/2018 - 04/2012
3	Atrial Fibrillation 01/2016 - 04/2012
2	Heart Failure 01/2018 - 02/2011
1	Postthrombotic Syndrome 07/2022
1	Myocardial Infarction 10/2018
1	Wound Infection (Wound Infections) 10/2018
1	Aortic Dissection 03/2017
1	Cardiogenic Shock 03/2017
1	Intermittent Claudication 01/2017
1	Right Ventricular Dysfunction 10/2013
1	Body Weight (Weight, Body) 10/2013
1	Kidney Diseases (Kidney Disease) 06/2013
1	Thromboembolism 06/2013
1	Ischemic Stroke 01/2013
1	Renal Insufficiency (Renal Failure) 04/2012
1	Neoplasms (Cancer) 07/2011
1	Shock 11/2003

5	Enoxaparin (Lovenox)FDA LinkGeneric 02/2018 - 07/2010
4	Heparin (Liquaemin)FDA LinkGeneric 10/2013 - 12/2010
4	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 07/2011 - 07/2010
3	AnticoagulantsIBA 01/2017 - 04/2012
3	certoparin (certoparin sodium)IBA 07/2011 - 12/2010
2	edoxabanIBA 07/2022 - 10/2013
2	Warfarin (Coumadin)FDA LinkGeneric 07/2022 - 10/2013
2	Vitamin K FDA Link 01/2016 - 05/2012
2	Dabigatran FDA Link 08/2015 - 04/2012
1	omega-Chloroacetophenone (Mace)IBA 10/2018
1	bemiparinIBA 02/2018
1	DiureticsIBA 01/2018
1	fibrin fragment D (D-dimer)IBA 01/2018
1	RivaroxabanIBA 03/2017
1	Fondaparinux (Arixtra)FDA Link 03/2017
1	Alprostadil (Muse)FDA LinkGeneric 01/2017
1	Pentoxifylline (Trental)FDA LinkGeneric 01/2017
1	Factor Xa InhibitorsIBA 10/2013
1	Brain Natriuretic Peptide (Natrecor)FDA Link 10/2013
1	CreatinineIBA 10/2013
1	Thrombin FDA Link 04/2012
1	cupric sulfide (CuS)IBA 02/2003

2	Therapeutics 03/2017 - 10/2013
1	Subcutaneous Injections 03/2017
1	Critical Care (Surgical Intensive Care) 07/2014
1	Indwelling Catheters (Indwelling Catheter) 06/2013
1	Cardiopulmonary Resuscitation (CPR) 11/2003